Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.09M | 8.26M | 8.02M | 7.09M | 6.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.09M | 8.26M | 8.02M | 7.09M | 6.59M |
| Cost of Revenue | 4.87M | 4.99M | 4.80M | 4.33M | 4.01M |
| Gross Profit | 3.22M | 3.27M | 3.22M | 2.77M | 2.57M |
| SG&A Expenses | 2.76M | 2.62M | 2.66M | 2.49M | 2.20M |
| Depreciation & Amortization | 194.00K | 233.40K | 208.90K | 196.80K | 148.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.83M | 7.85M | 7.67M | 7.02M | 6.36M |
| Operating Income | 261.90K | 418.60K | 350.40K | 75.20K | 221.20K |
| Income Before Tax | -63.90K | 586.90K | -578.50K | -76.50K | 1.08M |
| Income Tax Expenses | -10.20K | 160.70K | -94.50K | 1.80K | 194.80K |
| Earnings from Continuing Operations | -53.70K | 426.20K | -484.00K | -78.30K | 886.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.70K | 426.20K | -484.00K | -78.30K | 886.30K |
| EBIT | 261.90K | 418.60K | 350.40K | 75.20K | 221.20K |
| EBITDA | 383.70K | 652.00K | 559.30K | 271.90K | 290.70K |
| EPS Basic | 0.00 | 0.00 | -0.01 | 0.00 | 0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 90.63M | 87.31M | 87.31M | 87.31M | 83.04M |
| Average Diluted Shares Outstanding | 90.63M | 87.95M | 87.31M | 87.31M | 84.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |